STRS Ohio’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

STRS Ohio’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,900	Closed	-$1.04M	–	2341
2020 Q4	$1.04M	Sell	7,900 -4,100	-34%	-$362K	﹤0.01%	1033
2020 Q3	$606K	Hold	12,000	–	–	﹤0.01%	1217
2020 Q2	$572K	Buy	12,000 +500	+4%	+$23.3K	﹤0.01%	1210
2020 Q1	$563K	Hold	11,500	–	–	﹤0.01%	1046
2019 Q4	$659K	Sell	11,500 -200	-2%	-$9.9K	﹤0.01%	1236
2019 Q3	$420K	Hold	11,700	–	–	﹤0.01%	1381
2019 Q2	$363K	Buy	11,700 +9,600	+457%	+$260K	﹤0.01%	1463
2019 Q1	$49K	Hold	2,100	–	–	﹤0.01%	1893
2018 Q4	$28K	Hold	2,100	–	–	﹤0.01%	1959
2018 Q3	$20K	Buy	+2,100	New	+$34.5K	﹤0.01%	2039

STRS Ohio's EIDX Position: Q1 2021 in Review

STRS Ohio sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 7,900 shares — an estimated $1.04M sold.

STRS Ohio first reported a position in EIDX in Q3 2018 and held it in 10 quarters. The position peaked at $1.04M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

STRS Ohio reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
STRS Ohio sold 7,900 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.04M.
STRS Ohio first reported a position in Eidos Therapeutics, Inc. Common Stock in Q3 2018 and held it in 10 quarters.
STRS Ohio's Eidos Therapeutics, Inc. Common Stock position peaked at $1.04M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.